/NOT FOR DISTRIBUTION IN THE UNITED STATES/
- Little Green Pharma successfully completes second commercial medical cannabis harvest and commences sales to Australian patients.
- LGP’s products accepted into major statewide clinical trials for advanced cancer.
- LGP commences negotiations for exports to Germany.
- LGP negotiating to build a 400,000 square foot facility on a 500,000 square foot site.
MONTREAL, Oct. 5, 2018 /CNW Telbec/ – LGC Capital Ltd. (TSXV:LG) (“LGC”) is pleased to advise that Australian medical cannabis company Little Green Pharma (LGP) in which LGC has a 14.21% interest, has successfully completed harvest of its second commercial medical cannabis crop from its facility south of Perth in Western Australia.
This quarter, LGP successfully achieved another milestone having produced Australia’s first locally grown medicinal cannabis product as well